Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thai Doctors To Begin Beta-Thalassemia Treatment Trials In 2011

This article was originally published in PharmAsia News

Executive Summary

Thai researchers expect to begin trials at home this year on gene-therapy technology they have been developing and testing successfully in Paris. The joint research is into a beta-thalassemia blood disorder treatment that has been successful in weaning a Frenchman off a lifetime of transfusions. The Thai researchers involved in the experiment using gene therapy are from Ramathibodi Hospital, which expects to begin a trial in December. An estimated 20 million Thais carry the disorder, now treated with bone-marrow transplants. Click here for more) "Medical Leap Gives Hope To Blood-Disorder Sufferers" - Bangkok Post (Thailand) (1/3/10)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC076320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel